MNV-BM-PLC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MNV-BM-PLC, covering 2025-06-22 to 2025-06-22. Get the full timeline:
Most recent: Clinical Trial Update: A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion [Phase 1]